StrataDx Archives - PharmaDeviceNews

Fulgent Genetics acquires Bako Diagnostics and StrataDx to offset precision diagnostics headwind

By Pallavi Madhiraju on March 19, 2026 Medical Devices & Diagnostics

Fulgent Genetics closes $56.9M Bako and StrataDx acquisition. What it means for anatomic pathology growth, margin risk, and diagnostic consolidation in 2026.

Fulgent Genetics acquires Bako Diagnostics and StrataDx to expand AI pathology strategy

By Venkatesh B on January 1, 2026 Medical Devices & Diagnostics

Fulgent Genetics acquires Bako Diagnostics and StrataDx to scale AI pathology, expand national reach, and advance precision medicine strategy. Read full analysis.